A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Completed · Phase 1

Conditions studied: HIV Infections, Contraception, Pharmacokinetics

In brief

The purpose of this study is to determine if blood levels of the hormonal emergency contraceptive agent, Plan B, are altered by concomitant use with the HIV medication, efavirenz.

Key facts

Study ID

NCT00482963

Run by

University of Colorado, Denver

People needed

24

Starts

2007-05-01

Expected to finish

2008-12-01

Last updated by the study team

2013-07-15

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy, HIV-1 seronegative women of child-bearing age.

You may not qualify if…

• Current use of hormonal contraception
• Pregnancy/Breast Feeding
• Post-menopausal status
• Obesity
• Hepatitis B or C
• Psychiatric illness
• Active Substance Abuse

Where it is running

• University of Colorado Health Sciences Center — Denver, Colorado, United States
• The Miriam Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.